The Multiplex Molecular Diagnostics Market research report by Value Market Research, covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
The outbreak of the COVID-19 pandemic has brought massive loss to human life across the globe. To control the growing transmission of COVID-19, rapid testing measures are essential. The growing preference for RT-PCR testing kits as the standard of testing has invoked tremendous demand worldwide. This aspect may encourage the market manufacturers to expand their production capacity. In addition, technological advancement in molecular diagnosis is likely to drive the market. Further, modernization in molecular diagnostics and has cost-effectiveness, accuracy & profitability also become a significant factor in driving the growth of the multiplex molecular diagnosis technology market.
The major players in the multiplex molecular diagnostics market include BD, bioMérieux SA, GenMark Diagnostics, Inc, Hologic, Luminex Corporation and others.
By Product Type
- Analyzers
- Software
- Instruments
- Centrifuge
- Counting Chambers
- Incubators
By Method
- Real-time PCR
- Nested PCR With Melt Curve Analysis
- PCR With Low Density Microarray
- PCR With Liquid Phase Bead Array
- PCR With Electrochemical Detection
By End User Type
- Clinical Research Laboratory
- Hospitals
- Academic & Research Centers
- Others
The Multiplex Molecular Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Source: https://www.valuemarketresearch.com/report/multiplex-molecular-diagnostics-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.